Published in FEBS Lett on October 15, 1990
The oxytocin receptor system: structure, function, and regulation. Physiol Rev (2001) 6.97
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A (1999) 3.85
Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol (2000) 3.55
Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry (1995) 3.36
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A (2001) 2.87
Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol (2001) 2.20
Cholesterol as modulator of receptor function. Biochemistry (1997) 2.10
Regulation of receptor function by cholesterol. Cell Mol Life Sci (2000) 1.67
Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J (2001) 1.47
Cloning and nucleotide sequence of the structural genes encoding the formate dehydrogenase of Wolinella succinogenes. Arch Microbiol (1991) 1.10
The quinone-reactive Ni/Fe-hydrogenase of Wolinella succinogenes. Eur J Biochem (1992) 1.07
Isolation of intact FNR protein (Mr 30,000) of Escherichia coli. Mol Microbiol (1990) 1.04
Cloning and nucleotide sequence of the psrA gene of Wolinella succinogenes polysulphide reductase. Eur J Biochem (1992) 1.03
Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur J Biochem (2000) 1.02
Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry (1995) 1.01
Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. Eur J Biochem (1992) 1.01
The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. Biochem Biophys Res Commun (1995) 0.98
An extracellular residue determines the agonist specificity of V2 vasopressin receptors. FEBS Lett (1995) 0.97
Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach. Cell Tissue Res (2000) 0.96
Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress. Neuroscience (2008) 0.96
S-type lectins occur also in invertebrates: high conservation of the carbohydrate recognition domain in the lectin genes from the marine sponge Geodia cydonium. Glycobiology (1993) 0.95
Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor. Exp Cell Res (1998) 0.91
Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor. Biochemistry (1993) 0.91
Periplasmic sulphide dehydrogenase (Sud) from Wolinella succinogenes: isolation, nucleotide sequence of the sud gene and its expression in Escherichia coli. Eur J Biochem (1995) 0.90
Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J Biol Chem (1996) 0.90
Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin. J Biol Chem (1992) 0.90
Oxytocin receptors and cholesterol: interaction and regulation. Exp Physiol (2000) 0.88
Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors. J Biol Chem (1990) 0.88
Photocleavable biotinylated ligands for affinity chromatography. Anal Biochem (1994) 0.87
Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line. Eur J Biochem (1993) 0.87
The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature. EMBO J (1989) 0.86
Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics (1992) 0.86
Reconstitution of the myometrial oxytocin receptor into proteoliposomes. Dependence of oxytocin binding on cholesterol. Eur J Biochem (1994) 0.86
Autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney. Eur J Pharmacol (1989) 0.85
Direct identification of the agonist binding site in the human brain cholecystokininB receptor. Biochemistry (1999) 0.84
Photoaffinity labelling of the renal V2 vasopressin receptor. Identification and enrichment of a vasopressin-binding subunit. Eur J Biochem (1985) 0.83
Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase. J Biol Chem (1995) 0.83
Major proteolytic fragments of the murine band 3 protein as obtained after in situ proteolysis. Biochim Biophys Acta (1989) 0.83
Vasopressin V2-receptor mobile fraction and ligand-dependent adenylate cyclase activity are directly correlated in LLC-PK1 renal epithelial cells. J Cell Biol (1991) 0.82
Non-genomic effects of progesterone on the signaling function of G protein-coupled receptors. FEBS Lett (1999) 0.82
Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus. FEBS Lett (1994) 0.82
Lateral mobility of the phospholipase C-activating vasopressin V1-type receptor in A7r5 smooth muscle cells: a comparison with the adenylate cyclase-coupled V2-receptor. EMBO J (1990) 0.81
Interactions of vasopressin agonists and antagonists with membrane receptors. Eur J Pharmacol (1984) 0.81
Cloning and functional characterization of the amphibian mesotocin receptor, a member of the oxytocin/vasopressin receptor superfamily. Eur J Biochem (1996) 0.81
Photoaffinity labeling of the V1 vasopressin receptor in plasma membranes from rat liver. J Biol Chem (1985) 0.80
Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus. Mol Cell Endocrinol (2000) 0.80
Molecular cloning of substance P receptor cDNA from guinea-pig uterus. Biochim Biophys Acta (1992) 0.79
Solubilization of ligand-stabilized vasopressin receptors from plasma membranes of bovine kidney and rat liver. Biochem Biophys Res Commun (1983) 0.79
Photoaffinity labelling of the oxytocin receptor in plasma membranes from rat mammary gland. FEBS Lett (1989) 0.79
Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK1 renal epithelial cells: role of the cytoskeleton. Exp Cell Res (1990) 0.79
Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Solubilization, deglycosylation and purification. Eur J Biochem (1996) 0.79
Synthesis of p-amino-L-phenylalanine derivatives with protected p-amino group for preparation of p-azido-L-phenylalanine peptides. Int J Pept Protein Res (1980) 0.79
Reactivity of the N-terminal cysteine residues in active and inactive forms of FNR, and O2-responsive, Fe containing transcriptional regulator of Escherichia coli. J Inorg Biochem (1996) 0.78
Identification and enzymatic deglycosylation of the myometrial oxytocin receptor using a radioiodinated photoreactive antagonist. J Biol Chem (1991) 0.78
N-glycosylation plays a role in biosynthesis and internalization of the adenylate cyclase stimulating vasopressin V2-receptor of LLC-PK1 renal epithelial cells: an effect of concanavalin A on binding and expression. Arch Biochem Biophys (1992) 0.78
Long-term stimulation of cAMP production in LLC-PK1 pig kidney epithelial cells by salmon calcitonin or a photoactivatable analogue of vasopressin. Biochim Biophys Acta (1987) 0.78
Monensin-resistant LLC-PK1 cell mutants are affected in recycling of the adenylate cyclase-stimulating vasopressin V2-receptor. Mol Cell Endocrinol (1991) 0.78
Affinities of reactive vasopressin analogues for bovine antidiuretic receptor. Mol Cell Endocrinol (1983) 0.78
Photoaffinity labeling of central cholecystokinin receptors with high efficiency. Biochemistry (1993) 0.78
A low affinity vasopressin V2-receptor in inherited nephrogenic diabetes insipidus. J Recept Res (1992) 0.78
Structural requirements for V2 vasopressin receptor proteolytic cleavage. Eur J Biochem (1999) 0.77
Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells. Biochim Biophys Acta (1994) 0.77
Determination of the functional molecular size of vasopressin isoreceptors. FEBS Lett (1984) 0.77
Iodinated photoreactive vasopressin antagonists: labelling of hepatic vasopressin receptor subunits. Eur J Biochem (1986) 0.77
Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling. Adv Exp Med Biol (1998) 0.77
Lack of interaction of vasopressin with its antisense peptides: a functional and immunological study. J Recept Res (1993) 0.77
A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation. FEBS Lett (2000) 0.77
Photoaffinity labeling analysis of the interaction of pituitary adenylate-cyclase-activating polypeptide (PACAP) with the PACAP type I receptor. Eur J Biochem (1997) 0.77
Molecular modelling study of the role of cholesterol in the stimulation of the oxytocin receptor. Acta Biochim Pol (2001) 0.77
Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation. Eur J Biochem (1991) 0.76
The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxytocin receptor concentrations. Am J Obstet Gynecol (1991) 0.76
Oxytocin induced cAMP-dependent protein kinase activation and urokinase-type plasminogen activator production in LLC-PK1 renal epithelial cells is mediated by the vasopressin V2-receptor. FEBS Lett (1993) 0.76
Identification of binding domains of pituitary adenylate cyclase activating polypeptide (PACAP) for its type 1 receptor by photoaffinity labeling. Ann N Y Acad Sci (1998) 0.75
Biotinyl analogues of vasopressin as biologically active probes for vasopressin receptor expression in cultured cells. J Biol Chem (1990) 0.75
Synthesis of the central iron core of rubredoxin. J Am Chem Soc (1972) 0.75
Interaction of rat adenohypophyseal vasopressin receptors with vasopressin analogues substituted at positions 7 and 1: dissimilarity from the V1 vasopressin receptor. Neuroendocrinology (1986) 0.75
Preparation and characterization of biologically active iodo- and [3H]secretin. Anal Biochem (1978) 0.75
[Preparation of 4'-azido-2'-nitro-L-phenylalanine as label for amino acid transport systems in biological membranes (author's transl)]. Hoppe Seylers Z Physiol Chem (1975) 0.75
Synthesis of a chelated core related to rubredoxin. Amino acids and peptides. XXXV. Int J Pept Protein Res (1973) 0.75
Monoclonal antibodies against different epitopes of peptide hormones. Use of photoreactive analogues in studies on vasopressin. Eur J Biochem (1990) 0.75
Persistent stimulation of adenylate cyclase and urea transport by an AVP photolabel. Am J Physiol (1985) 0.75
A major Litomosoides carinii microfilarial sheath glycoprotein (gp22): amino terminal sequence and immunological studies with corresponding synthetic peptides. Parasitology (1991) 0.75
Isolation and genetic characterization of a renal epithelial cell mutant defective in vasopressin (V2) receptor binding and function. Exp Cell Res (1991) 0.75
Synthesis and biological activities of arginine-vasopressin analogues with reactive groups. Hoppe Seylers Z Physiol Chem (1980) 0.75
Photoreactive neurohypophyseal hormone analogs: effects on transport processes in mammalian and amphibian epithelia. Endocrinology (1986) 0.75
[1,6-alpha-aminosuberic acid,3-(p-azidophenylalanine), 8-arginine] vasopressin as a photoaffinity label for renal vasopressin receptors: an evaluation. Biochem Biophys Res Commun (1984) 0.75
[Tritium-labeled reactive analogs of [1,6-alpha-aminosuberic acid, 8-arginine] vasopressin (deamino-dicarba-[8-arginine] vasopressin. synthesis and properties]. Hoppe Seylers Z Physiol Chem (1982) 0.75
Action of photoreactive analogs of vasopressin in toad bladder. Biol Cell (1985) 0.75
Covalent linkage of [Phe2,Phe(p-N3)3]AVP to vasopressin receptors. Am J Physiol (1984) 0.75
Vasopressin binding sites in toad bladder: studies with the photoaffinity analogue [Phe(p-N3)3]AVP. Am J Physiol (1986) 0.75
[Components of the green deathcap toadstool, amanita phalloides. XLII. Peptide syntheses. 48. Synthesis of norphalloin and of a monocyclic compound with 18-membered ring]. Justus Liebigs Ann Chem (1971) 0.75
Enhanced selectivity of oxytocin antagonists containing sarcosine in position 7. J Med Chem (1994) 0.75
A system to select for mutant LLC-PK1 cells affected in cAMP mediated hormonal response using a photoactivatable analogue of vasopressin. J Recept Res (1990) 0.75
Synthesis and binding characteristics of two sulfhydryl-reactive probes for vasopressin receptors. FEBS Lett (1993) 0.75
Irreversible stimulation of hydroosmotic response in toad bladder by photoaffinity labeling with [Phe2,Phe-(p-N3)3]Vasopressin. Endocrinology (1983) 0.75
Simple method for the synthesis of some boc-amino acids. Angew Chem Int Ed Engl (1972) 0.75
Generation of anti-idiotypic monoclonal antibodies recognizing vasopressin receptors in cultured cells and kidney sections. Exp Cell Res (1992) 0.75